Evidence map›Paper›PMID 37672473›Full record

ArticleArquivos brasileiros de cardiologia2023

Brazilian Registry of Interventional Cardiology during the COVID-19 Pandemic (RBCI-COVID19).

Viviana Guzzo Lemke, Maria Sanali Souza Paiva, Giordana Zeferino Mariano, Thales Siqueira Alves, Esmeralci Ferreira, Leonardo Avany Nunes, Flavio Roberto Azevedo Oliveira, Rodrigo Cantarelli, Emilia Matos do Nascimento, Gláucia Maria Moraes de Oliveira

Open access · diamondAbstract read
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Viviana Guzzo LemkeCardiocare, Curitiba, PR - Brasil.ORCID 0000-0002-0732-9920
Maria Sanali Souza PaivaHospital Universitário Onofre Lopes - HUOL, Natal, RN - Brasil.ORCID 0000-0002-6457-3217
Giordana Zeferino MarianoHospital São João Batista, Criciúma, SC - Brasil.ORCID 0000-0002-6346-9602
Thales Siqueira AlvesHospital Universitário Pedro Ernesto, Rio de Janeiro, RJ - Brasil.ORCID 0000-0002-7980-572X
Esmeralci FerreiraUniversidade do Estado do Rio de Janeiro - Doenças do Tórax, Rio de Janeiro, RJ - Brasil.ORCID 0000-0003-3230-7683
Leonardo Avany NunesHospital São João Batista, Criciúma, SC - Brasil.ORCID 0000-0002-1617-8482
Flavio Roberto Azevedo OliveiraHospital Dom Helder Câmara, Recife, PE - Brasil.
Rodrigo CantarelliUniversidade do Estado do Rio de Janeiro, Rio de Janeito, RJ - Brasil.ORCID 0000-0002-5147-7875
Emilia Matos do NascimentoUniversidade do Estado do Rio de Janeiro, Rio de Janeito, RJ - Brasil.ORCID 0000-0001-8313-8766
Gláucia Maria Moraes de OliveiraUniversidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brasil.ORCID 0000-0002-0737-6188
Weatherford College · USHospital Universitário Onofre Lopes · BRHospital Universitário Pedro Ernesto · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAt the beginning of the COVID-19 pandemic, patients with myocardial infarction (MI) took longer to present to hospitals because of fear of contamination and health care access difficulties.

objectivesTo assess interventional cardiology procedures performed during the COVID-19 pandemic and its implications for MI approach.

methodsProspective registry of 24 cardiac catheterization laboratories in Brazil, with adult patients undergoing interventional cardiology procedures between May 26 and November 30, 2020. The outcomes were cardiovascular (CV) and non-CV complications, death, and MI. Concomitant COVID-19 was confirmed using RT-PCR. Machine learning techniques were used with nonparametric Classification Trees models, and Simple Correspondence Analysis, with R statistical software package. Significance level adopted of 5%.

resultsThis study included 1282 patients, 435 of whom (33.9%) had MI as follows: ST-segment elevation MI (STEMI), 239 (54.9%); and non-ST-segment elevation MI (NSTEMI), 196 (45.1%). Of the 1282 patients, 29 had CV complications, 47 had non-CV complications, and 31 died. The diagnosis of COVID-19 was confirmed in 77 patients (6%), with 15.58% mortality and non-CV complications in 6.49%. Most patients had significant coronary artery disease (63%), and an intracoronary thrombus was more often found in the presence of STEMI (3.4%) and COVID-19 (4%). A door-to-table time longer than 12 hours in NSTEMI was associated with 30.8% of complications, 25% in COVID-19 patients.

conclusionsAll deaths were preceded by CV or non-CV complications. The presence of COVID-19 was associated with death and non-fatal complications of patients undergoing interventional cardiology procedures during the pandemic.

Indexed as

CardiologyCOVID-19Myocardial InfarctionNon-ST Elevated Myocardial InfarctionST Elevation Myocardial InfarctionAdultBrazilHumansPandemics

Identifiers

PMID37672473
PMCPMC10519241
OpenAlexW4386091978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.